ReviewJournal of inflammation research2024

The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.